Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fe(II)-protoporphyrin IX, commonly known as heme or protoheme IX, is a metalloporphyrin complex where an iron(II) (ferrous) ion is coordinated at the center of the protoporphyrin IX macrocycle. This molecule serves as a critical prosthetic group in various hemoproteins, including hemoglobin, myoglobin, and cytochromes. It is essential for oxygen transport, storage, and electron transfer. While not a direct drug target itself, its role in malaria pigment formation makes related enzymes and pathways potential therapeutic targets.
Endogenous inhibitor of hematin polymerization (in malaria parasites)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fe(II)-protoporphyrin IX (Heme).